ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

BM-219 is under clinical development by Suzhou Biomissile Biopharmaceutical and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

Watsco is a great business with a remarkable historical track record. Click here to read why I have a neutral rating on WSO ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

The World Bank in its latest report has highly appreciated the policies and the high tech moves of the Vietnam Government and ...

The war between Russia and Ukraine has now entered its 1044th day since starting on February 24, 2022. In this relatively short time, drones have become a bona fide tour de force on the battlefield.

Street photographer Christopher Ward has amassed more than a million followers by capturing the wisdom of strangers in ...

Bottom Line partners with students from first-generation and low-income backgrounds to provide one-on-one mentorship and ...

EVs are growing in popularity worldwide, but most Americans need help affording plug-in vehicles because they still cost more ...

Industry sources speak of pragmatism and cautious approach to project economics to drive energy transition bandwagon in 2025 ...